Gregory Sargen's Net Worth

$16.2 Million

Estimate Recalculated Jul 18, 2024 03:07PM EST

Who is Gregory Sargen?

Gregory Sargen has an estimated net worth of $16.2 Million. This is based on reported shares across multiple companies, which include Avid Bioservices, Inc., CAMBREX CORP, and Protara Therapeutics, Inc..

SEC CIK

Gregory Sargen's CIK is 0001227835

Past Insider Trading and Trends

2015 was Gregory Sargen's most active year for acquiring shares with 17 total transactions. Gregory Sargen's most active month to acquire stocks was the month of October. 2006 was Gregory Sargen's most active year for disposing of shares, totalling 30 transactions. Gregory Sargen's most active month to dispose stocks was the month of October. 2006 saw Gregory Sargen paying a total of $1,655,177.50 for 90,500 shares, this is the most they've acquired in one year. In 2019 Gregory Sargen cashed out on 171,727 shares for a total of $10,172,784.90, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Avid Bioservices, Inc. (CDMO) Snapshot price: $6.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
9.61K
—
—
9.61K
Dec 14
Form 4
-100.00%
-7.01K
$20.24
-$141,918.77
0
Apr 11
Form 4
+194.70%
4.63K
—
—
7.01K
Dec 14
Form 4
∞
2.38K
—
—
2.38K
Dec 14
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Nov 27
Form 3
—
0
—
—
0
No matching records found

CAMBREX CORP No price found

CFO & EVP, Corp. Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-32.42K
$51.57
-$6,073,925.00
0
Dec 4
Form 4
+23.63%
6.2K
$37.45
-$217,284.90
32.42K
Feb 15
Form 4
+31.14%
6.23K
—
—
26.23K
Jan 31
Form 4
—
0
—
—
0
Oct 24
Form 4
—
0
$40.55
-$2,154,234.77
20K
May 7 - May 8
Form 4
—
0
—
—
0
Oct 30
Form 4
—
0
$54.88
-$1,646,400.00
20K
Feb 7
Form 4
—
0
$33.88
-$816,600.00
20K
Nov 11
Form 4
—
0
—
—
0
Oct 26
Form 4
∞
26.7K
$41.37
$1,104,454.89
20K
Mar 9
Form 4
+40.15%
13.38K
$36.16
-$492,525.86
46.7K
Feb 11
Form 4
—
0
$31.35
-$1,023,212.50
33.32K
Nov 13
Form 4
—
0
—
—
0
Oct 21
Form 4
—
0
$29.90
-$1,625,062.50
33.32K
Aug 3 - Aug 4
Form 4
—
0
$21.41
-$851,512.50
33.32K
May 11
Form 4
—
0
$18.51
-$706,482.50
33.32K
Feb 12
Form 4
—
0
—
—
0
Oct 22
Form 4
—
0
$13.93
-$841,480.00
33.32K
Aug 5
Form 4
—
0
$14.50
-$551,812.00
33.32K
Feb 18
Form 4
—
0
$12.22
-$268,169.21
33.32K
Nov 11
Form 4
—
0
—
—
0
Oct 28
Form 4
—
0
$9.90
-$12,575.25
33.32K
May 7 - May 7
Form 4
—
0
—
—
0
Oct 24
Form 4
—
0
—
—
0
Oct 18
Form 4
—
0
—
—
0
Apr 21
Form 4
+233.57%
22.68K
—
—
32.4K
Feb 1
Form 4
-100.00%
-1.26K
—
—
0
May 19
Form 4
—
0
—
—
0
Apr 23
Form 4
+234.53%
15.7K
—
—
22.39K
Dec 31 - Jan 24
Form 4
+450.00%
4.5K
—
—
5.5K
Jul 26
Form 4
—
0
—
—
0
May 4
Form 4
+2,520.00%
25.2K
$20.84
$255,624.50
26.6K
Aug 23 - Nov 15
Form 4
∞
1K
—
—
1K
Jul 27
Form 4
—
0
—
—
0
Jul 25
Form 4
—
0
—
—
0
No matching records found

Protara Therapeutics, Inc. (TARA) Snapshot price: $2.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
∞
31K
—
—
31K
Jan 10
Form 3
—
0
—
—
0
No matching records found